Focusing The Bulls-Eye on These Stocks: BioTelemetry, Inc. (NasdaqGS:BEAT), BioSpecifics Technologies Corp. (NasdaqGM:BSTC)

Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of BioTelemetry, Inc. (NasdaqGS:BEAT) is 45.885000.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of BioTelemetry, Inc. (NasdaqGS:BEAT) is 58.091000.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 49.146500.

There are many factors that can affect the health of a certain company. Because of this, it can be extremely difficult to find one single strategy that will prove successful in the stock market. Investors are able to study all the different data, but figuring out the relevant information can be a struggle. There is plenty of company information that can easily be measured such as revenue and profits. There are also elements that aren’t as easily computed such as reputation and competitive advantage. Finding a way to gather all the information and craft a strategy that incorporates all aspects of a company may be a challenge for investors. Because there is a highly inherent human element to picking stocks, price action may not follow expectations. Human emotion can reverse course rapidly over a short period of time. Investors need to always be prepared for market uncertainty while attempting to keep emotions in check. 

At the time of writing, BioTelemetry, Inc. (NasdaqGS:BEAT) has a Piotroski F-Score of 6. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.

Some of the best financial predictions are formed by using a variety of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks.  The Price Range of BioTelemetry, Inc. (NasdaqGS:BEAT) over the past 52 weeks is 0.877000.  The 52-week range can be found in the stock’s quote summary. 

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow.  The FCF Growth of BioTelemetry, Inc. (NasdaqGS:BEAT) is 0.504464.  Free cash flow (FCF) is the cash produced by the company minus capital expenditure.  This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends.  The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow.  The FCF Score of BioTelemetry, Inc. is 0.903066.  Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

We can now take a quick look at some historical stock price index data. BioTelemetry, Inc. (NasdaqGS:BEAT) presently has a 10 month price index of 1.91656. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 2.15492, the 24 month is 3.08804, and the 36 month is 5.41443. Narrowing in a bit closer, the 5 month price index is 1.31179, the 3 month is 1.07746, and the 1 month is currently 1.03946.

Investors may be interested in viewing the Gross Margin score on shares of BioTelemetry, Inc. (NasdaqGS:BEAT). The name currently has a score of 38.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative. The Q.i. Value of BioTelemetry, Inc. is 50.00000.  The Q.i. Value is a helpful tool in determining if a company is undervalued or not.  The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity.  The lower the Q.i. value, the more undervalued the company is thought to be.

The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price.  The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital.  The MF Rank of BioTelemetry, Inc. (NasdaqGS:BEAT) is 5964.  A company with a low rank is considered a good company to invest in.  The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.  The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.  The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.  The ERP5 of BioTelemetry, Inc. (NasdaqGS:BEAT) is 7769.  The lower the ERP5 rank, the more undervalued a company is thought to be.

Traders often prefer to focus on stocks that are higher in volatility. Higher volatility brings more opportunity for quick profits, but it can also bring quick losses. Traders will typically try to understand recent stock activity in order to make the most out of the price action. Seeing how a certain stock has traded previously may allow traders to project which way shares will move in the near future. It is highly important for active traders to know the risk involved with trying to capitalize on shorter-term price movements. Adept traders are generally able to focus on the bigger picture and not let one or two bad trades get them down. Developing confidence to trade in the stock market may take substantial time and effort. Defining long term and short term goals to help keep the focus intact may help traders secure profits.

The 12 month volatility of BioSpecifics Technologies Corp. (NasdaqGM:BSTC) is 23.800200.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of BioSpecifics Technologies Corp. (NasdaqGM:BSTC) is 43.343800.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 42.584800.

Investors may be watching the ebb and flow of the current market environment and be wondering what the next few months have in store. They may be deciding whether now is a good time to sell off some first half winners or hold on for further gains. This can be one of the toughest decisions that an investor has to make. Just because a stock has been steadily heading higher for an extended period of time doesn’t necessarily mean that it will continue to do so. Building the confidence to make the tough portfolio decisions may take some time and a few good trades under the belt. New investors may be prone to get discouraged after a few sour trades in a row. Anyone who wants to succeed in the stock market knows that there is no substitute for research and hard work. Being able to bounce back and learn from mistakes may help the investor stay in the game and get back on the road to healthy profits.

We can now take a quick look at some historical stock price index data. BioSpecifics Technologies Corp. (NasdaqGM:BSTC) presently has a 10 month price index of 1.53495. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 1.35922, the 24 month is 1.16663, and the 36 month is 1.40279. Narrowing in a bit closer, the 5 month price index is 1.31150, the 3 month is 1.04060, and the 1 month is currently 1.06576.

At the time of writing, BioSpecifics Technologies Corp. (NasdaqGM:BSTC) has a Piotroski F-Score of 4. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.

Investors may be interested in viewing the Gross Margin score on shares of BioSpecifics Technologies Corp. (NasdaqGM:BSTC). The name currently has a score of 36.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative. The Q.i. Value of BioSpecifics Technologies Corp. is 36.00000.  The Q.i. Value is a helpful tool in determining if a company is undervalued or not.  The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity.  The lower the Q.i. value, the more undervalued the company is thought to be.

The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price.  The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital.  The MF Rank of BioSpecifics Technologies Corp. (NasdaqGM:BSTC) is 3098.  A company with a low rank is considered a good company to invest in.  The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.  The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.  The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.  The ERP5 of BioSpecifics Technologies Corp. (NasdaqGM:BSTC) is 4164.  The lower the ERP5 rank, the more undervalued a company is thought to be.

Some of the best financial predictions are formed by using a variety of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks.  The Price Range of BioSpecifics Technologies Corp. (NasdaqGM:BSTC) over the past 52 weeks is 0.943000.  The 52-week range can be found in the stock’s quote summary. 

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow.  The FCF Growth of BioSpecifics Technologies Corp. (NasdaqGM:BSTC) is -0.193723.  Free cash flow (FCF) is the cash produced by the company minus capital expenditure.  This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends.  The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow.  The FCF Score of BioSpecifics Technologies Corp. is 0.496185.  Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

Stock market investing can sometimes be a wild ride. High volatility stocks may seem to constantly going haywire. Finding a comfortable balance between stomach turning stocks and low volatility stable stocks may be the way to go. Building confidence in the stock portfolio may come with some trial and error for the individual investor. Many people will rely on others to actively manage their money, but there are always those who prefer to have a hand in every aspect of their hard earned cash. Staying on top of the markets may seem impossible sometimes. There is always something happening, and keeping the pulse on market movements may be quite a struggle. Applying the proper amount of time to dedicate for stock research might just be the difference between buying that next big winner or getting stuck with a big loser. 

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.